Brief: ExpreS2ion Biotech Q2 Operating Income at SEK 2.069 Million
17/08/2023 08:16
Aug 17 (Reuters) - ExpreS2ion Biotech Q2 EPS SEK -0.63. * Q2 net income SEK -30.038 million * Q2 operating income SEK 2.069 million
Recent news on ExpreS2ion Biotech Holding AB
See all newsBrief: Expres2ion Biotech To Raise SEK 19.3 Million From Warrants And Share Issue
Brief: ExpreS2ion Reports Q2 Loss Of SEK 9.7 Million
Brief: Expres2ion Biotech Says DSMB Recommends Expanding 450 Μg Cohort
Brief: Expres2ion Biotech Holding Q1 2026 Operating Income SEK 6.87 Mln
Brief: Expres2ion Updates ES2B-C001 Phase I Programme and Reports Additional Preliminary Immunogenicity and Safety Observations